KRAS and vascular neoplasm: Vascular tumor thrombus was additionally found in two of four LAMPC patients with KRAS mutations, but not in patients with wild-type KRAS, suggesting that LAMPC patients with KRAS mutations are more likely to develop vascular tumor thrombus (p = 0.0129, Figure 4D and Table 5).